AMRN Insider Trading
Insider Ownership Percentage: 1.96%
Insider Buying (Last 12 Months): $102,400.00
Insider Selling (Last 12 Months): $0.00
Amarin Share Price & Price History
Current Price: $0.44
Price Change: ▼ Price Decrease of -0.0271 (-5.80%)
As of 03/28/2025 05:00 PM ET
Amarin Insider Trading History
Amarin Institutional Trading History
Data available starting January 2016
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Read More on Amarin
Volume
1,130,697 shs
Average Volume
1,388,887 shs
Market Capitalization
$180.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.82
Who are the company insiders with the largest holdings of Amarin?
Who are the major institutional investors of Amarin?
Which major investors are selling Amarin stock?
During the last quarter, AMRN stock was sold by these institutional investors:
- Eversept Partners LP
- Longitude Cayman Ltd.
- Two Sigma Advisers LP
- Two Sigma Investments LP
- OneDigital Investment Advisors LLC
- Commonwealth Equity Services LLC
- Cutter & CO Brokerage Inc.
- Ameriprise Financial Inc.
Which major investors are buying Amarin stock?
In the last quarter, AMRN stock was bought by institutional investors including:
- Waterfront Wealth Inc.
- AXA S.A.
- Raymond James Financial Inc.
- Raymond James Financial Inc.
- Quinn Opportunity Partners LLC
- Mercer Global Advisors Inc. ADV
- Jane Street Group LLC
- Sei Investments Co.
In the previous year, these company insiders have bought Amarin stock:
- Aaron Berg (CEO)
- Steven B Ketchum (Insider)
Learn More investors buying Amarin stock.